Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	Bortezomib	Bortezomib	1件: D03150 💬	1件: PSMB5 💬	8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
2	Bortezomib (velcade®)	Bortezomib	1件: D03150 💬	1件: PSMB5 💬	8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 66 💬
3	Bortezomib/dexamethasone	Bortezomib	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬	2件: NR3C1, PSMB5 💬	9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 283 💬
4	Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone	Bortezomib	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬	2件: NR3C1, PSMB5 💬	9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 28 💬
5	Combination of a single dose anti-cd20 antibody and bortezomib	Bortezomib	1件: D03150 💬	1件: PSMB5 💬	8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 61 💬
6	Cyclophosphamide, bortezomib, and dexamethasone (cybord)	Bortezomib	12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬	2件: NR3C1, PSMB5 💬	9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 28 💬
7	Cyclophosphamide, bortezomib, dexamethasone	Bortezomib	12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬	2件: NR3C1, PSMB5 💬	9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 28 💬
8	Cyclophosphamide, bortezomib, dexamethasone plus daratumumab	Bortezomib	13件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760, D10777 💬	3件: CD38, NR3C1, PSMB5 💬	16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia	1件: 28 💬
9	Velcade	-	-	-	-	5件: 11, 28, 46, 49, 61 💬
10	Velcade*1fl 3,5mg	-	-	-	-	1件: 28 💬
11	Velcade*ev 1fl 3,5mg 1mg/ml	-	-	-	-	1件: 61 💬
12	Velcade®	-	-	-	-	3件: 11, 46, 49 💬